Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jan 15, 2009

Premium

AnaSpec last week introduced its newest ClearPoint heavy or isotope-labeled peptides and amino acids.

The peptides can be used for the quantitative analysis of beta-amyloid peptides in biological fluids using mass spectrometry. Beta-amyloid peptides have been used as biomarkers for Alzheimer's disease. ELISAs have been used to quantify these peptides, but technical challenges such as the tendency of beta-amyloids to self-aggregate, undergo post-translational modification, or bind to other proteins can lead to inaccurate results, AnaSpec said in a statement.

"The inclusion of internal heavy isotope labeled peptide standards makes mass spectrometry an absolute quantitation method for the peptide of interest," the company said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more